Derek S. Welsbie

7.9k total citations · 3 hit papers
39 papers, 5.5k citations indexed

About

Derek S. Welsbie is a scholar working on Molecular Biology, Ophthalmology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Derek S. Welsbie has authored 39 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Ophthalmology and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Derek S. Welsbie's work include Glaucoma and retinal disorders (12 papers), Retinal Development and Disorders (8 papers) and Retinal Imaging and Analysis (6 papers). Derek S. Welsbie is often cited by papers focused on Glaucoma and retinal disorders (12 papers), Retinal Development and Disorders (8 papers) and Retinal Imaging and Analysis (6 papers). Derek S. Welsbie collaborates with scholars based in United States, Germany and Netherlands. Derek S. Welsbie's co-authors include Charles L. Sawyers, Chris Tran, Michael G. Rosenfeld, Sung Hee Baek, Robert L. Vessella, Michael E. Jung, Howard I. Scher, Yu Chen, Tomasz M. Beer and Celestia S. Higano and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Derek S. Welsbie

38 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular determinants of resistance to antiandrogen therapy

2003 1.8k citations Derek S. Welsbie, Chris Tran et al. Nature Medicine profile →
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer

2009 1.7k citations Chris Tran, Samedy Ouk et al. Science profile →
Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer

2005 507 citations George Thomas, Chris Tran et al. Nature Medicine profile →

Peers

Countries citing papers authored by Derek S. Welsbie

Since Specialization

Citations

This map shows the geographic impact of Derek S. Welsbie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek S. Welsbie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek S. Welsbie more than expected).

Fields of papers citing papers by Derek S. Welsbie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derek S. Welsbie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek S. Welsbie. The network helps show where Derek S. Welsbie may publish in the future.

Co-authorship network of co-authors of Derek S. Welsbie

This figure shows the co-authorship network connecting the top 25 collaborators of Derek S. Welsbie. A scholar is included among the top collaborators of Derek S. Welsbie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derek S. Welsbie. Derek S. Welsbie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Osteopontin drives retinal ganglion cell resiliency in glaucomatous optic neuropathy 2023 ·Cell Reports ·Mengya Zhao, Kenichi Toma, Benyam Kinde, Liang Li, Amit K. Patel, Kong-Yan Wu, (unknown), (unknown), Jody E. Hooper, Arnold R. Kriegstein, Anna La Torre, Yaping Joyce Liao, Derek S. Welsbie, Yang Hu, Ying Han, Xin Duan	14
2	Traumatic Axonal Injury in the Optic Nerve: The Selective Role of SARM1 in the Evolution of Distal Axonopathy 2023 ·Journal of Neurotrauma ·(unknown), (unknown), Mohamed Lehar, (unknown), (unknown), (unknown), Jiwon Ryu, Derek S. Welsbie, Donald J. Zack, Vassilis E. Koliatsos	9
3	Defining functional requirements for a patient-centric computerized glaucoma treatment and care ecosystem 2023 ·(unknown), Simon E. Skalicky, Robert N. Weinreb, Ricardo Augusto Paletta Guedes, Christophe Baudouin, Xiulan Zhang, Aukje van Gestel, Eytan Z. Blumenthal, Paul L. Kaufman, Robert Rothman, (unknown), Paul Harasymowycz, Derek S. Welsbie, Ivan Goldberg	3
4	A Deep Learning Approach to Improve Retinal Structural Predictions and Aid Glaucoma Neuroprotective Clinical Trial Design 2022 ·Ophthalmology Glaucoma ·Mark Christopher, (unknown), (unknown), James A. Proudfoot, Christopher Bowd, Massimo A. Fazio, Christopher A. Girkin, Carlos Gustavo De Moraes, Jeffrey M. Liebmann, Robert N. Weinreb, Armin Schwartzman, Linda M. Zangwill, Derek S. Welsbie	11
5	Superior segmental optic nerve hypoplasia: A review 2022 ·Survey of Ophthalmology ·Jo‐Hsuan Wu, Chao‐Wen Lin, Chun-Hsiu Liu, Robert N. Weinreb, Derek S. Welsbie	0
6	Qualitative Evaluation of the 10-2 and 24-2 Visual Field Tests for Detecting Central Visual Field Abnormalities in Glaucoma 2021 ·American Journal of Ophthalmology ·(unknown), Ghee Soon Ang, Andrew Camp, Derek S. Welsbie, Felipe A. Medeiros, Christopher A. Girkin, Massimo A. Fazio, (unknown), Robert N. Weinreb, Linda M. Zangwill, Zhichao Wu	15
7	Progressive Thinning of Retinal Nerve Fiber Layer and Ganglion Cell–Inner Plexiform Layer in Glaucoma Eyes with Disc Hemorrhage 2021 ·Ophthalmology Glaucoma ·(unknown), (unknown), Huiyuan Hou, Sasan Moghimi, James A. Proudfoot, (unknown), L. Jiun, Andrew Camp, Derek S. Welsbie, Carlos Gustavo De Moraes, Christopher A. Girkin, Jeffrey M. Liebmann, Robert N. Weinreb	5
8	Potential of Ocular Transmission of SARS-CoV-2: A Review 2020 ·Vision ·Brad P. Barnett, Karl Wahlin, Michał Krawczyk, Doran Spencer, Derek S. Welsbie, Natalie A. Afshari, Daniel L. Chao	32
9	A Randomized Controlled Trial Comparing Subconjunctival Injection to Direct Scleral Application of Mitomycin C in Trabeculectomy 2020 ·American Journal of Ophthalmology ·L. Jiun, Benjamin Y. Xu, Brandon Wong, Andrew Camp, (unknown), (unknown), James A. Proudfoot, Sasan Moghimi, (unknown), Derek S. Welsbie, Robert N. Weinreb	23
10	Inhibition of GCK-IV kinases dissociates cell death and axon regeneration in CNS neurons 2020 ·Proceedings of the National Academy of Sciences ·Amit K. Patel, Risa Broyer, (unknown), (unknown), (unknown), Anna La Torre, Hassan Al‐Ali, (unknown), Katherine L. Mitchell, Karl Wahlin, Cynthia Berlinicke, Vinod Jaskula-Ranga, Yang Hu, Xin Duan, Santiago Vilar, John L. Bixby, Robert N. Weinreb, Vance Lemmon, Donald J. Zack, Derek S. Welsbie	21
11	Sheath-Preserving Optic Nerve Transection in Rats to Assess Axon Regeneration and Interventions Targeting the Retinal Ganglion Cell Axon 2020 ·Journal of Visualized Experiments ·L. Jiun, (unknown), (unknown), Robert N. Weinreb, Derek S. Welsbie	2
12	Targeted disruption of dual leucine zipper kinase and leucine zipper kinase promotes neuronal survival in a model of diffuse traumatic brain injury 2019 ·Molecular Neurodegeneration ·Derek S. Welsbie, (unknown), Leyan Xu, Byung-Jin Kim, Yusong Ge, Amit K. Patel, Jiwon Ryu, Mohamed Lehar, (unknown), (unknown), Donald J. Zack, Vassilis E. Koliatsos	27
13	Thyroid hormone signaling specifies cone subtypes in human retinal organoids 2018 ·Science ·Kiara C. Eldred, Sarah E. Hadyniak, Katarzyna A. Hussey, Boris Brenerman, Ping-Wu Zhang, Xitiz Chamling, Valentin M. Sluch, Derek S. Welsbie, Samer Hattar, James Taylor, Karl Wahlin, Donald J. Zack, Robert J. Johnston	185
14	More Than Just Optic Disc Swelling 2013 ·JAMA Ophthalmology ·Roomasa Channa, Derek S. Welsbie, Vivek Patel	1
15	Histone Deacetylases Are Required for Androgen Receptor Function in Hormone-Sensitive and Castrate-Resistant Prostate Cancer 2009 ·Cancer Research ·Derek S. Welsbie, Jin Xu, Yu Chen, Laetitia Borsu, Howard I. Scher, Neal Rosen, Charles L. Sawyers	144
16	Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer breakdown → 2009 ·Science ·Chris Tran, Samedy Ouk, Nicola J. Clegg, Yu Chen, Philip A. Watson, Vivek Arora, John Wongvipat, Peter Smith‐Jones, Dongwon Yoo, Andrew Kwon, Teresa Wasielewska, Derek S. Welsbie, (unknown), Celestia S. Higano, Tomasz M. Beer, David T. Hung, Howard I. Scher, Michael E. Jung, Charles L. Sawyers	1689
17	Ligand-specific allosteric regulation of coactivator functions of androgen receptor in prostate cancer cells 2006 ·Proceedings of the National Academy of Sciences ·Sung Hee Baek, Kenneth A. Ohgi, Charles A. Nelson, Derek S. Welsbie, Charlie Chen, Charles L. Sawyers, David W. Rose, Michael G. Rosenfeld	62
18	Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer breakdown → 2005 ·Nature Medicine ·George Thomas, Chris Tran, Ingo K. Mellinghoff, Derek S. Welsbie, Emily Chan, Barbara J. Fueger, Johannes Czernin, Charles L. Sawyers	507
19	Molecular determinants of resistance to antiandrogen therapy breakdown → 2003 ·Nature Medicine ·(unknown), Derek S. Welsbie, Chris Tran, Sung Hee Baek, (unknown), Robert L. Vessella, Michael G. Rosenfeld, Charles L. Sawyers	1796
20	Epoxyisoprostane E2-containing phospholipids in oxidized low density lipoprotein and atherosclerotic lesions 1999 ·Journal of Investigative Medicine ·Andrew D. Watson, Ganesamoorthy Subbanagounder, Kym F. Faull, Norbert Leitinger, Derek S. Welsbie, Susan Hama, Mohamad Navab, Alan M. Fogelman, Judith A. Berliner	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact